Kanazawa, Japan - 25-28 March, 2018
SpiroChem will be participating to the 138th Annual Meeting of the Pharmaceutical Society of Japan, held in Kanazawa from 25-28 March, 2018. Professor Erick M. Carreira, from ETH Zürich and Member of the Board of Directors at SpiroChem; will be delivering a lecture on the “Recent Developments in Strategies and Tactics Towards Complex Secondary Metabolites Including Human-Derived Natural Products” while our CEO, Dr. Thomas Fessard, will be able to meet you at the exhibition floor to discuss how SpiroChem’s innovative approach supports and improves the discovery of next-generation drugs.
Contact: Dr. Thomas Fessard
E-mail: thomas.fessard@spirochem.com
